07 Jan 2001

Maxilase 3000 - España

Updated: 07 Jan 2001

Maxilase 3000 3000 u ceip 20 capsulas

Edemas posttraumáticos por contusiones, fracturas, luxaciones, etc. Edemas postquirúrgicos. Extracciones dentales.

Maxilase 3000 Description, Presentation and Dosage

Maxilase 3000 Description

Maxilase 3000 Drug Class Description

Enzimas antiinflamatorios

Maxilase 3000 Drug Description


Maxilase 3000 Presentation

Maxilase 3000 Presentation

Adultos: Dosis usual: 2 cápsulas 3 veces al día.

Maxilase 3000 Manufacturer


Related Learning Zones

CLL Knowledge Centre

CLL Knowledge Centre

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within three main sections: ‘Disease awareness’, ‘Events’ and ‘Resources’. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing.

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

Maxilase 3000 Dosage

Maxilase 3000 Precautions, Reactions and Contraindications

Maxilase 3000 Special Precautions

Related Drugs - Sistema nervioso central

Back to top